CSL LIMITED

0.81%

$199.95

Market Cap $97.24B

Healthcare Biotechnology

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag

Subject

CSL

CSL Chart

18 19 20

13:32

1.1K

739K

13:32

Last post Vanguardian78

1.1K

739K

CSL

Why is CSL tanking

5 6 7

11:56

381

174K

11:56

Last post E38

381

174K

CSL

Ann: Update - Notification of buy-back - CSL

11:25

728

11:25

Last post nyquistt

728

CSL

Ann: CSL partners on new coagulation treatment

09:38

7.9K

09:38

Last post dbd25

7.9K

CSL

The chart really couldn’t look much uglier

09:29

15K

09:29

Last post TheAnalyst007

15K

CSL

CSL R&D Spend

04:27

224

04:27

Last post snosh

224

CSL

CSL v ASX One Day Domestic

18/09/25

602

18/09/25

Last post evo118

602

CSL

Ann: Update - Notification of buy-back - CSL

18/09/25

287

18/09/25

Last post

ASX News

287

See All Discussions

Timeline

Update - Notification of buy-back - CSL
19 Sep 08:25	Share

Update - Notification of buy-back - CSL
18 Sep 08:26	Share

CSL Notice of Meeting and Shareholder Pack
17 Sep 08:24	Share

CSL partners on new coagulation treatment
16 Sep 08:01	Share

Update - Notification of buy-back - CSL
15 Sep 08:24	Share

Update - Dividend/Distribution - CSL
12 Sep 12:01	Share

Update - Notification of buy-back - CSL
12 Sep 08:23	Share

Update - Notification of buy-back - CSL
11 Sep 08:26	Share

Notification regarding unquoted securities - CSL
10 Sep 09:40	Share

Application for quotation of securities - CSL
10 Sep 09:33	Share

Update - Notification of buy-back - CSL
10 Sep 08:25	Share

Update - Notification of buy-back - CSL
09 Sep 08:28	Share

Update - Notification of buy-back - CSL
08 Sep 08:24	Share

Change of Director's Interest Notice
05 Sep 16:05	Share

Notification of cessation of securities - CSL
05 Sep 11:07	Share

Notification of cessation of securities - CSL
05 Sep 11:06	Share

Update - Notification of buy-back - CSL
05 Sep 08:26	Share

Application for quotation of securities - CSL
04 Sep 09:18	Share

Update - Notification of buy-back - CSL
03 Sep 18:16	Share

Change of Director's Interest Notice x 9
29 Aug 10:02	Share

Notification regarding unquoted securities - CSL
29 Aug 09:56	Share

Change of Director's Interest Notice
27 Aug 10:59	Share

Notification regarding unquoted securities - CSL
27 Aug 10:05	Share

Notification of buy-back - CSL
20 Aug 14:38	Share

Appendix 4G and Corporate Governance Statement
19 Aug 07:41	Share

CSL Results Presentation
19 Aug 07:40	Share

Dividend/Distribution - CSL
19 Aug 07:40	Share

CSL FY25 Results and Major Strategic Initiatives
19 Aug 07:40	Share

CSL Statutory Accounts for FY2025
19 Aug 07:40	Share

Notice of Investor/Analyst Briefing 2025 Full Year Result
18 Aug 15:54	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $199.95		Change 1.610(0.81%)		Mkt cap ! $97.24B

Open	High	Low	Value	Volume
$200.98	$203.69	$199.92	$313.9M	1.406M

Buyers (Bids)

No.	Vol.	Price($)
2	8	$199.94

Sellers (Offers)

Price($)	Vol.	No.
$199.96	80	8

View Market Depth

No.	Vol.	Price($)
110	4608	200.000
9	38	199.990
8	58	199.980
8	196	199.970
6	133	199.960

Price($)	Vol.	No.
200.030	205	12
200.040	65	7
200.050	116	6
200.060	98	3
200.070	91	5

Last trade - 14.10pm 19/09/2025 (20 minute delay)


Last $200.09		Change 1.610 ( 0.34 %)
Open	High	Low	Volume
$200.88	$203.66	$199.89	76072
Last updated 14.31pm 19/09/2025 ?

CSL (ASX) Chart

CSL LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

CSL price walloped -10% on widespread 'cost-saving' job cuts, Seqirus spinoff plans

Earnings day hasn’t quite been a shining one for CSL Ltd (ASX:CSL), with the $117 billion biotechnology bluechip unveiling plans to trim its global workforce by as much as 15% as it looks to save $550 million annually.Listen to the HotCopper podcast for in-depth discussions and in...

Biotech stocks that survived April 2 feel the heat of Trump's new pharma threat

If you thought a 104% tariff on China was bad enough, Trump’s found another way to make the markets about himself @ now confirming major tariffs on pharmaceuticals.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout th...

CSL survives a brutal sell-off but dips on US tariff response as investors eye pharma risk

CSL Ltd (ASX:CSL) has seen shares fall nearly half a percent in afternoon trades on Thursday as the company responds to Trump's US tariffs.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News